Back to search
FDAFDA · Food and drugs·Recall number Z-2685-2020

TRIGEN, Intramedullary nail - Product Usage: is intended to provide resistance for screw back-out. It provides additional friction to help hold the screws in place.

Published July 29, 2020 · Recall initiated: June 24, 2020

Summary

FDA records medical device Class II recall Z-2685-2020, published July 29, 2020 and initiated June 24, 2020. Recalling firm: Smith & Nephew, Inc.; Status: Terminated; Reported quantity: 12 units; Lot: Model: 71655139 Lot: 19BM13592A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A manufacturing error which resulted in the re-sterilization of the ultra-high-molecular-weight polyethylene (UHMWPE) sleeve.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Smith & Nephew, Inc.
Distributor
International distribution in the countries of Brazil, Colombia and United Arab Emirates.
Lot
Model: 71655139 Lot: 19BM13592A
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was TRIGEN, Intramedullary nail - Product Usage: is intended to provide resistance for screw back-out. It provides additional friction to help hold the screws in place. recalled?

Yes. FDA published recall Z-2685-2020 on July 29, 2020. Reported hazard: A manufacturing error which resulted in the re-sterilization of the ultra-high-molecular-weight polyethylene (UHMWPE) sleeve.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail